1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
- Read more in our News Archive
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy ForumArchived Questions and Answers
This Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
Dosing of antineoplastic drugs during pregnancy:
Several reviews exist in which possible changes in the pharmacokinetics of antineoplastic agents are described (Volume of distribution, Clearance, amniotic fluid as a "third space" etc.). Are there any recommendations or dose-modifications for antineoplastics during pregnancy with respect to the above mentioned pharmacokinetic changes? Is the current body-weight or the weight before pregnancy used for calculation of body-surface ?
Pregnancy is indeed associated with various pharmacokinetic changes. Even with regard to non-cancer conditions, very few drugs have been formally compared in pregnancy vs. postpartum. Presently we are not aware of any such studies with cancer chemotherapy in pregnancy. Consequently, there are no changes in dose guidelines for pregnancy. One may hypothesize that for most agents, either renally or hepatically eliminated, levels in pregnancy will be lower and potentially, effect may decrease.